XRAY Dentsply Sirona · $14.05 Neutral — no clear edge中性 — 无明显优势 Terminal终端
Dentsply Sirona · Health Care

XRAY

$14.05
Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.DentsplySironaInc.是一家美国牙科设备制造商和牙科耗材生产商,其产品销往超过120个国家。
Speculative / unprofitable投机/未盈利 Mid cap中盘 $3B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
Trend intact — hold. Late in the cycle, so don't add here; a pullback is due.趋势完好——持有。已处周期晚期,此处不宜加仓;回调即将到来。
Open in Terminal打开终端 All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$14.05
14.3% below 52-week high低于52周高点 14.3%
Market Cap市值
$3B
Normal volume正常成交量
Beta贝塔
1.37
Moves about 1.4x the market波动幅度约为市场的 1.4 倍
RSI (14)RSI(14)
78
Overbought超买区域
Next Earnings下次财报
2026-08-06 (18d)
Volatility Rank波动率分位
62th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
14.6% of float

Performance价格表现

Period周期 XRAY S&P 500vs Index对比指数
1 Week近1周 +14.6% -1.5% Beat the index by 16.1 points跑赢指数 16.1 个百分点
1 Month近1月 +40.1% +0.6% Beat the index by 39.5 points跑赢指数 39.5 个百分点
3 Months近3月 +12.3% +4.7% Beat the index by 7.6 points跑赢指数 7.6 个百分点
6 Months近6月 +15.1% +7.8% Beat the index by 7.3 points跑赢指数 7.3 个百分点
Year to date年初至今 +24.7% +9.1% Beat the index by 15.6 points跑赢指数 15.6 个百分点
1 Year近1年 -8.5% +19.4% Lagged the index by 27.9 points落后指数 27.9 个百分点
3 Years近3年 -62.4% +69.4% Lagged the index by 131.8 points落后指数 131.8 个百分点

Technicals技术面

RSI (14)RSI(14) 78 Overbought超买区域
vs 50-day相对50日均线 +29.7% vs 50-day avg
vs 200-day相对200日均线 +20.0% vs 200-day avg
Volatility rank波动率分位 62th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$12.69
Don't chase above不追高于
$14.05
Stop止损
$10.03
Hold — don't add here持有 — 此处不宜加仓

Earnings财务业绩

18
days until next report天后公布财报
2026-08-06

Estimates being cut预期下调

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 XRAY Sector median行业中位 Cheaper than相对便宜
P/B市净率 2.09x 3.52
72%
P/S市销率 0.76x 3.02
88%
Earnings yield盈利收益率 -21.32% 2.72
6%
FCF yield自由现金流收益率 3.71% 3.94
46%
Shareholder yield股东收益率 0.00% 1.89
6%
P/FCF市值/自由现金流 26.97x 22.42
37%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$3.3B
2020
$4.2B
2021
$3.9B
2022
$4.0B
2023
$3.8B
2024
$3.7B
2025
5yr CAGR5年复合增速: 1.9%
Earnings Per Share每股收益
$-0.38
2020
$1.87
2021
$-4.41
2022
$-0.62
2023
$-4.48
2024
$-3.00
2025
Free Cash Flow自由现金流
$548.0M
2020
$515.0M
2021
$368.0M
2022
$228.0M
2023
$281.0M
2024
$104.0M
2025
Margins利润率
Gross margin毛利率
50.0%
Operating margin营业利润率
-11.5%
Net margin净利率
-16.2%
FCF margin自由现金流利润率
6.4%
-44.7%Return on Equity股本回报率
-11.0%Return on Assets资产回报率
Leverage杠杆
Current ratio流动比率1.51
Capital Allocation资本配置
Stock-based comp股权薪酬$33.0M
Share count change (1y)股数变化(1年)+0.4%
Piotroski皮奥特罗斯基 5/9 Altman Z阿尔特曼Z: distress (0.6) Watch关注

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 69% of its sector on blended multiples综合估值倍数低于行业内 69% 的公司
Beta市场敏感度
1.37×
0.2
Moves about 1.4× the market波动幅度约为市场的 1.4 倍
Financial Health财务健康
5/9
Altman阿尔特曼: distress
Adequate financial health财务健康状况一般
Dividend分红
Does not pay a dividend不派发股息

Why Is It Moving为何波动

Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed +18.2%空头仓位变动 +18.2%
Technical技术面 XRAY took relative-strength leadershipXRAY 取得相对强弱领先

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: +$0.2M net (3 buyers, 1 sellers)+$0.2M 净值(3 买家,1 卖家)

Signal History信号历史

BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD. The weekly (investor-cycle) momentum just crossed UP while price holds its 10-day average — the start of a new multi-month up-leg. A daily-overbought print here is the launch thrust, not a top, so this is a HOLD / ride, not a take-profit. The daily can still dip to its 10-day average (normal) — but the bigger investor cycle is early, with room left. Last cycle was left-translated (topped early) — a bearish structural tell持有。周线(投资者周期)动量刚刚向上交叉,且价格守住 10 日均线——这是新的多月上行段的起点。此处日线超买只是启动推力、并非见顶,因此应持有 / 顺势,而非止盈。日线仍可能回踩 10 日均线(属正常)——但更大的投资者周期尚处早期,仍有空间。 上一周期为左移结构(见顶偏早)——属于看空的结构性信号
RALLY ON UPTREND
Jul 16, 2026
XRAY took relative-strength leadershipXRAY 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $13.85.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$13.85。
Jul 15, 2026
XRAY RSI reached overboughtXRAY RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $13.40.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$13.40。
Jul 13, 2026
XRAY RSI reached overboughtXRAY RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $12.78.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$12.78。
Jul 9, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD持有
Jul 7, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Jul 6, 2026
BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD持有
Jul 6, 2026
XRAY reclaimed its 200-day averageXRAY 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $12.32.收盘重回200日均线 — 经典的多头分界线。$12.32。
Jul 6, 2026
XRAY RSI reached overboughtXRAY RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $12.32.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$12.32。

Showing last 15 of显示最近15条,共 237 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.21
Value价值
-1.1
Profitability盈利能力
+0.1
Quality质量
+0.3
Investment资本投入
+0.8
Shareholder payout股东回报
-1.0
Low volatility低波动
-0.5
Low market beta低市场敏感度
-0.7
Earnings quality盈利质量
+1.7
Short interest空头兴趣
-0.8

Company Profile公司档案

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.DentsplySironaInc.是一家美国牙科设备制造商和牙科耗材生产商,其产品销往超过120个国家。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
  • Inventory build
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析,覆盖所有标普500成分股。